HCW Biologics Inc.
HCW Biologics Secures up to $10.0 Million in Cash Through Debt Financing
Provides funding needed to complete HCW9302 Phase 1 study in alopecia areata and establish Recommended Phase 2 Dose
Company newsroom
HCW Biologics Inc.
NASDAQ:HCWB
1 releases